Using the CARDIOSIM numerical simulation platform, researchers modeled two configurations of the Impella RP right ventricular assist device (RVAD): the clinically standard right atrium-to-pulmonary artery (RA-PA) connection and an investigational right ventricle-to-pulmonary artery (RV-PA) configuration. When systemic venous pressure and pulmonary artery wedge pressure were both set to 20 mmHg — mimicking decompensated right heart failure — activating the device in RA-PA mode elevated mean pulmonary artery pressure above unsupported conditions regardless of pump speed. Crucially, switching to RV-PA connection produced a similar hemodynamic trend but reduced pulmonary artery pressure changes by roughly half, suggesting superior right ventricular unloading potential.
This is a preprint posted on medRxiv and has not yet undergone peer review, so conclusions must be treated cautiously. The finding matters because right heart failure remains one of the most lethal complications following left ventricular assist device implantation and cardiac transplantation, yet RVAD options are limited and poorly optimized. The simulation-based approach allows exploration of cannulation strategies that would be ethically or logistically difficult to test clinically first. However, pure computational modeling carries significant limitations: patient heterogeneity, myocardial contractility variability, and real-world catheter positioning are abstracted away. No human outcome data are presented. This work is best characterized as hypothesis-generating and incremental — valuable for guiding future device trials — rather than practice-changing. Clinical validation in adequately powered prospective studies will be essential before RV-PA cannulation enters routine consideration.